Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH analogue ovarian protection during cyclophosphamide-based chemotherapy in reproductive-age women
ACTRN12609001059257Phase 2Recruiting
- Sponsor
- Ass. Prof. Dr. Eman Elgindy
- Start
- Dec 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of triptorelin and cetrorelix in cancer (4 arms), sponsored by Ass. Prof. Dr. Eman Elgindy. Primary endpoint: Resumption of menstruation. Started Dec 2009; status: recruiting.
02
Drugs
triptorelincetrorelix
03
Conditions
cancer
Beyond the preview
Go deeper on ACTRN12609001059257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609001059257.